950 — Lees Pharmaceutical Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapSuper Stock

Annual balance sheet for Lees Pharmaceutical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	HKAS	HKAS	HKAS	HKAS	HKAS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	415	278	189	171	217
Net Total Accounts Receivable
Net Total Receivables	386	354	213	185	280
Total Inventory
Total Other Current Assets
Total Current Assets	1,239	963	652	657	785
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	725	688	541	443	401
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	3,253	3,637	2,782	2,891	2,618
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	944	923	650	649	771
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Liabilities	1,103	1,172	858	852	966
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	2,150	2,465	1,924	2,039	1,652
Total Liabilities & Shareholders' Equity	3,253	3,637	2,782	2,891	2,618
Total Common Shares Outstanding